Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04079179
Title Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders (NACHO COBI)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Carl Allen
Indications

juvenile xanthogranuloma

Erdheim-Chester disease

histiocytosis

Therapies

Cobimetinib

Age Groups: child | senior | adult
Covered Countries USA


No variant requirements are available.